Galapagos, CHDI Foundation Collaborate For Huntington’s Disease Therapeutics
Galapagos’ service division BioFocus is expected to perform the research and eligible to receive $41m (EUR31m) in research fees during the five-year collaboration. BioFocus is expected to apply
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.